Report : Middle East and Africa Molecular Quality Controls Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Independent Controls, and Instrument Specific Controls), Analyte Type (Single Analyte Controls, and Multi Analyte Controls), Application (Infectious Diseases, Oncology, Genetic Testing, and Other Applications), and End User (Clinical Laboratories, Hospitals, IVD Manufacturers & Contract Research Organizations, Academic & Research Institutes, and Other End Users)

The independent controls segment by product is estimated to lead the market growth during the forecast period.

According to a new market research study of “Middle East and Africa Molecular Quality Controls Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Product, Analyte Type, Application, End User and Country.” The Middle East and Africa molecular quality controls market is expected to reach US$ 109.59 million by 2028 from US$ 55.76 million in 2021; it is estimated to grow at a CAGR of 10.1% from 2021 to 2028. The report highlights trends prevailing in the Middle East and Africa molecular quality controls market and the factors driving market along with those that act as hindrances.

The Middle East and Africa molecular quality controls market, by product, is segmented into independent controls and instrument specific controls. The independent controls segment held the largest share of the market in 2020 whereas the same is anticipated to register the highest CAGR in the market during the forecast period.

Genome sequencing has now become one of the common techniques in clinical practices. As per the study ‘Integrating Genomics into Healthcare’, over the next a few years, the healthcare sector is expected to generate genomic data of over 60 million patients. The growing implementation of genomic sequencing in healthcare systems is supported by substantial government investments, totaling over US$ 4 billion by at least 14 countries. Such continuous funding by the manufacturers and governments in the field of genomics is supporting the growth of the molecular quality controls market. Also, the cost of genome sequencing, as well as next-generation sequencing, has dropped radically in the past 6–7 years. Moreover, the process requires a lesser number of days for completion. Lowering costs and accelerating overall process enable service providers to secure larger profit margins, along with helping them expand their clientele. Thus, the lowered cost of genome sequencing is propelling the number of molecular biology procedures carried out for different purpose, thereby driving the use of molecular quality controls. Additionally, molecular diagnostics methodologies are used for detecting disturbance between specific sequences in DNA or RNA. The irregularities such as single nucleotide polymorphism (SNP), deletions, rearrangements, and insertions lead to various diseases—such as infectious diseases, cancer, viral diseases, and sexually transmitted diseases (STDs). Hence, high prevalence of infectious diseases and increasing incidence of cancer lead to high traction toward molecular diagnostics, as it is capable of diagnosing diseases with high specificity, further paving the way for treating patients with precision medicine. Various governments are focused on research and development in the field of precision medicine.

The recent pandemic is causing turbulence to the economies of the Middle East region. The Saudi government policies are favored of domestic pharmaceutical manufacturers including not any import duties on raw materials & intermediate products and interest-free funding support the growth of the pharmaceutical market in this region. Similarly, increasing incidence of COVID-19 create huge demand for kits and reagent used in detection of COVID-19 virus. As molecular quality controls majorly used in detection of novel coronavirus, so there was positive impact of COVID-19 on the molecular quality controls market.

Factors such as growing funds for genomics, declining cost of sequencing procedures, and increasing prevalence of genetic diseases fuel the growth of the market. However, the dearth of skilled professionals hinders the market growth.

THERMO FISHER SCIENTIFIC INC., BIO-RAD LABORATORIES INC., HOFFMANN-LA ROCHE LTD., Abbott, Quidel Corporation, Qnostics, Maine Molecular Quality Controls Inc., Zeptometrix Corporation, Microbiologics, and Seracare Life Sciences are among the leading companies operating in the Middle East and Africa molecular quality controls market.

The report segments in Middle East and Africa Molecular Quality Controls Market as follows:

By Product

  • Independent Controls
  • Instrument Specific Controls
    • PCR
    • DNA Sequencing and NGS

By Analyte Type

  • Single Analyte Controls
  • Multi Analyte Controls

By Application

  • Infectious Diseases
  • Oncology
  • Genetic Testing
  • Other Applications

By End User    

  • Clinical Laboratories
  • Hospitals
  • IVD Manufacturers & Contract Research Organizations
  • Academic & Research Institutes
  • Other End Users

By Country

  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East and Africa

Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com

Download Free PDF Brochure